S.L. Malcolm
Impact in
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Cancer, Hypoxia, and Metabolism 3
-
- Epigenetics and DNA Methylation 1
- Co-authors
- I. R. Flockhart (2 shared papers)C. R. Scriver (1 shared paper)G. Curzon (1 shared paper)G Rylance (1 shared paper)Jean Chapple (1 shared paper)Ian R. McDonald (1 shared paper)Ann Stewart (1 shared paper)Linda Tyfield (1 shared paper)
- Journals
- Xenobiotica (2 papers)Analytical Chemistry (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)Clinica Chimica Acta (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United KingdomAustraliaDenmark
In The Last Decade
S.L. Malcolm
13 papers receiving 459 citations
Peers
Comparison fields: 5 of 84
- Clinical Biochemistry 219
- Pharmacology 56
- Cancer Research 64
- Physiology 106
- Pharmaceutical Science 26
Countries citing papers authored by S.L. Malcolm
This map shows the geographic impact of S.L. Malcolm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.L. Malcolm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.L. Malcolm more than expected).
Fields of papers citing papers by S.L. Malcolm
This network shows the impact of papers produced by S.L. Malcolm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.L. Malcolm. The network helps show where S.L. Malcolm may publish in the future.
Co-authors
The 25 scholars most cited alongside S.L. Malcolm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 226 | |
| 2 | 1978 | 80 | |
| 3 | 1976 | 46 | |
| 4 | 1977 | 40 | |
| 5 | 1982 | 26 | |
| 6 | 1984 | 20 | |
| 7 | 1983 | 19 | |
| 8 | 1973 | 14 | |
| 9 | Some aspects of the metabolism of misonidazole. | 1978 | 12 |
| 10 | 2008 | 8 | |
| 11 | 1990 | 8 | |
| 12 | 1983 | 6 | |
| 13 | 2008 | 5 |
About S.L. Malcolm
S.L. Malcolm is a scholar working on Cancer Research, Molecular Biology, Pharmaceutical Science, Pulmonary and Respiratory Medicine and Physiology, having authored 13 papers that have together received 510 indexed citations. Recurring topics across this work include Chemical Reactions and Isotopes (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Radiation Therapy and Dosimetry (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Analytical Chemistry and Chromatography (2 papers), Diet and metabolism studies (1 paper), Vitamin C and Antioxidants Research (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Clinical Biochemistry (219 citations), Pharmacology (56 citations), Cancer Research (64 citations), Physiology (106 citations) and Pharmaceutical Science (26 citations). S.L. Malcolm has collaborated with scholars based in United Kingdom, Australia and Denmark. Frequent co-authors include I. R. Flockhart, C. R. Scriver, G. Curzon, G Rylance, Jean Chapple, Ian R. McDonald, Ann Stewart, Linda Tyfield, M. J. Whittle and D. P. Brenton. Their work appears in journals such as Xenobiotica, Analytical Chemistry, Journal of Pharmaceutical and Biomedical Analysis, Clinica Chimica Acta and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.